Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-023496
Filing Date
2025-05-08
Accepted
2025-05-08 08:53:09
Documents
68
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vcel-20250331.htm   iXBRL 10-Q 914635
2 EX-10.1 employmentagreementbyandbe.htm EX-10.1 82130
3 EX-31.1 ex311ceocertificationq12025.htm EX-31.1 13484
4 EX-31.2 ex312cfocertificationq12025.htm EX-31.2 11561
5 EX-32.1 ex321ceoandcfosoxcertifica.htm EX-32.1 9381
  Complete submission text file 0001628280-25-023496.txt   5611538

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcel-20250331.xsd EX-101.SCH 31641
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vcel-20250331_cal.xml EX-101.CAL 65680
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vcel-20250331_def.xml EX-101.DEF 143963
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcel-20250331_lab.xml EX-101.LAB 520881
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcel-20250331_pre.xml EX-101.PRE 337680
71 EXTRACTED XBRL INSTANCE DOCUMENT vcel-20250331_htm.xml XML 780005
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

EIN.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35280 | Film No.: 25924111
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)